DaVita HealthCare Partners Inc. (NYSE:DVA) gapped up prior to trading on Wednesday . The stock had previously closed at $53.23, but opened at $54.32. DaVita HealthCare Partners shares last traded at $55.34, with a volume of 2,674,991 shares changing hands.

A number of equities research analysts have weighed in on the stock. Jefferies Group LLC reissued a “hold” rating and issued a $70.00 price target on shares of DaVita HealthCare Partners in a report on Thursday, August 3rd. Zacks Investment Research downgraded shares of DaVita HealthCare Partners from a “hold” rating to a “sell” rating in a report on Wednesday. KeyCorp reissued a “hold” rating on shares of DaVita HealthCare Partners in a report on Tuesday. TheStreet downgraded shares of DaVita HealthCare Partners from a “b” rating to a “c+” rating in a report on Wednesday, August 2nd. Finally, BidaskClub downgraded shares of DaVita HealthCare Partners from a “sell” rating to a “strong sell” rating in a report on Saturday, August 5th. Four analysts have rated the stock with a sell rating, six have assigned a hold rating and one has issued a buy rating to the company’s stock. DaVita HealthCare Partners currently has an average rating of “Hold” and an average price target of $66.50.

DaVita HealthCare Partners (NYSE:DVA) last issued its earnings results on Tuesday, August 1st. The company reported $0.92 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.90 by $0.02. DaVita HealthCare Partners had a return on equity of 14.02% and a net margin of 8.68%. The firm had revenue of $3.88 billion for the quarter, compared to analysts’ expectations of $3.82 billion. During the same quarter last year, the business earned $1.01 earnings per share. The company’s revenue was up 4.3% compared to the same quarter last year.

DaVita HealthCare Partners declared that its Board of Directors has initiated a share buyback program on Tuesday, October 10th that authorizes the company to buyback $1.50 billion in outstanding shares. This buyback authorization authorizes the company to buy shares of its stock through open market purchases. Stock buyback programs are typically an indication that the company’s management believes its shares are undervalued.

Institutional investors and hedge funds have recently modified their holdings of the business. Pzena Investment Management LLC boosted its holdings in DaVita HealthCare Partners by 2.1% during the second quarter. Pzena Investment Management LLC now owns 3,398 shares of the company’s stock worth $220,000 after buying an additional 71 shares during the last quarter. Kovitz Investment Group Partners LLC bought a new position in DaVita HealthCare Partners during the first quarter worth about $289,000. Eqis Capital Management Inc. boosted its holdings in DaVita HealthCare Partners by 2.2% during the second quarter. Eqis Capital Management Inc. now owns 4,600 shares of the company’s stock worth $298,000 after buying an additional 100 shares during the last quarter. First Financial Equity Corporation bought a new position in DaVita HealthCare Partners during the first quarter worth about $304,000. Finally, Thrivent Financial For Lutherans boosted its holdings in DaVita HealthCare Partners by 4.4% during the first quarter. Thrivent Financial For Lutherans now owns 5,730 shares of the company’s stock worth $389,000 after buying an additional 240 shares during the last quarter. Hedge funds and other institutional investors own 83.27% of the company’s stock.

TRADEMARK VIOLATION NOTICE: This news story was published by The Cerbat Gem and is the property of of The Cerbat Gem. If you are reading this news story on another domain, it was copied illegally and republished in violation of US & international copyright and trademark legislation. The legal version of this news story can be accessed at https://www.thecerbatgem.com/2017/10/13/davita-healthcare-partners-inc-dva-shares-gap-up-to-54-32.html.

DaVita HealthCare Partners Company Profile

DaVita Inc, formerly DaVita HealthCare Partners Inc, operates two divisions: DaVita Kidney Care (Kidney Care) and DaVita Medical Group (DMG). The Kidney Care division consists of its the United States dialysis and related lab services, its ancillary services and strategic initiatives, including its international operations, and its corporate administrative support.

Receive News & Stock Ratings for DaVita HealthCare Partners Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DaVita HealthCare Partners Inc. and related stocks with our FREE daily email newsletter.